Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 88 of 88 entries
Sorted by: Best Match Show Resources per page
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques.

Journal of addiction medicine

Graves RL, Perrone J, Al-Garadi MA, Yang YC, Love JS, O'Connor K, Gonzalez-Hernandez G, Sarker A.
PMID: 34864788
J Addict Med. 2021 Dec 03; doi: 10.1097/ADM.0000000000000940. Epub 2021 Dec 03.

BACKGROUND: Opioid use disorder (OUD) is a major public health crisis for which buprenorphine-naloxone is an effective evidence-based treatment. Analysis of Reddit data yields detailed information about firsthand experiences with buprenorphine-naloxone that has the potential to inform treatment of...

Cite
Graves RL, Perrone J, Al-Garadi MA, et al. Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques. J Addict Med. 2021;doi: 10.1097/ADM.0000000000000940.
Graves, R. L., Perrone, J., Al-Garadi, M. A., Yang, Y. C., Love, J. S., O'Connor, K., Gonzalez-Hernandez, G., & Sarker, A. (2021). Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques. Journal of addiction medicine, . https://doi.org/10.1097/ADM.0000000000000940
Graves, Rachel Lynn, et al. "Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques." Journal of addiction medicine vol. (2021). doi: https://doi.org/10.1097/ADM.0000000000000940
Graves RL, Perrone J, Al-Garadi MA, Yang YC, Love JS, O'Connor K, Gonzalez-Hernandez G, Sarker A. Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques. J Addict Med. 2021 Dec 03; doi: 10.1097/ADM.0000000000000940. Epub 2021 Dec 03. PMID: 34864788.
Copy Download .nbib Format: NLM
Efficacy of mepolizumab in usual clinical practice and characteristics of responders.

Respiratory medicine

Rodríguez-García C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, Gonzalez-Fernandez C, Mosteiro-Añon M, Calvo-Alvarez U, Perez-De-Llano L, Corbacho-Abelaira MD, Lourido-Cebreiro T, Dominguez-Juncal LM, Crespo-Diz C, Dacal-Quintas R, Pallares-Sanmartin A, Dacal-Rivas D, Gonzalez-Barcala FJ.
PMID: 34492540
Respir Med. 2021 Oct;187:106595. doi: 10.1016/j.rmed.2021.106595. Epub 2021 Sep 02.

BACKGROUND: Severe eosinophilic asthma is a high-burden disease. Mepolizumab has been effective in several randomized clinical trials. However, such success might not be applicable to patients treated in usual clinical practice. The objectives of this article are to evaluate...

Cite
Rodríguez-García C, Blanco-Aparicio M, Nieto-Fontarigo JJ, et al. Efficacy of mepolizumab in usual clinical practice and characteristics of responders. Respir Med. 2021;187:106595doi: 10.1016/j.rmed.2021.106595.
Rodríguez-García, C., Blanco-Aparicio, M., Nieto-Fontarigo, J. J., Blanco-Cid, N., Gonzalez-Fernandez, C., Mosteiro-Añon, M., Calvo-Alvarez, U., Perez-De-Llano, L., Corbacho-Abelaira, M. D., Lourido-Cebreiro, T., Dominguez-Juncal, L. M., Crespo-Diz, C., Dacal-Quintas, R., Pallares-Sanmartin, A., Dacal-Rivas, D., & Gonzalez-Barcala, F. J. (2021). Efficacy of mepolizumab in usual clinical practice and characteristics of responders. Respiratory medicine, 187106595. https://doi.org/10.1016/j.rmed.2021.106595
Rodríguez-García, Carlota, et al. "Efficacy of mepolizumab in usual clinical practice and characteristics of responders." Respiratory medicine vol. 187 (2021): 106595. doi: https://doi.org/10.1016/j.rmed.2021.106595
Rodríguez-García C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, Gonzalez-Fernandez C, Mosteiro-Añon M, Calvo-Alvarez U, Perez-De-Llano L, Corbacho-Abelaira MD, Lourido-Cebreiro T, Dominguez-Juncal LM, Crespo-Diz C, Dacal-Quintas R, Pallares-Sanmartin A, Dacal-Rivas D, Gonzalez-Barcala FJ. Efficacy of mepolizumab in usual clinical practice and characteristics of responders. Respir Med. 2021 Oct;187:106595. doi: 10.1016/j.rmed.2021.106595. Epub 2021 Sep 02. PMID: 34492540.
Copy Download .nbib Format: NLM
Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification.

JMIR formative research

Klein AZ, O'Connor K, Gonzalez-Hernandez G.
PMID: 34870607
JMIR Form Res. 2022 Jan 06;6(1):e33792. doi: 10.2196/33792.

BACKGROUND: COVID-19 during pregnancy is associated with an increased risk of maternal death, intensive care unit admission, and preterm birth; however, many people who are pregnant refuse to receive COVID-19 vaccination because of a lack of safety data.OBJECTIVE: The...

Cite
Klein AZ, O'Connor K, Gonzalez-Hernandez G. Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification. JMIR Form Res. 2022;6(1):e33792doi: 10.2196/33792.
Klein, A. Z., O'Connor, K., & Gonzalez-Hernandez, G. (2022). Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification. JMIR formative research, 6(1), e33792. https://doi.org/10.2196/33792
Klein, Ari Z, et al. "Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification." JMIR formative research vol. 6,1 (2022): e33792. doi: https://doi.org/10.2196/33792
Klein AZ, O'Connor K, Gonzalez-Hernandez G. Toward Using Twitter Data to Monitor COVID-19 Vaccine Safety in Pregnancy: Proof-of-Concept Study of Cohort Identification. JMIR Form Res. 2022 Jan 06;6(1):e33792. doi: 10.2196/33792. PMID: 34870607.
Copy Download .nbib Format: NLM
The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases.

Physiological genomics

Gonzalez-Fernandez E, Fan L, Wang S, Liu Y, Gao W, Thomas KN, Fan F, Roman RJ.
PMID: 34859687
Physiol Genomics. 2021 Dec 03; doi: 10.1152/physiolgenomics.00119.2021. Epub 2021 Dec 03.

Hypertension is a leading risk factor for stroke, heart disease, chronic kidney disease, vascular cognitive impairment, and Alzheimer's disease. Previous genetic studies have nominated hundreds of genes linked to hypertension and renal and cognitive diseases. Some have been advanced...

Cite
Gonzalez-Fernandez E, Fan L, Wang S, et al. The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases. Physiol Genomics. 2021;doi: 10.1152/physiolgenomics.00119.2021.
Gonzalez-Fernandez, E., Fan, L., Wang, S., Liu, Y., Gao, W., Thomas, K. N., Fan, F., & Roman, R. J. (2021). The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases. Physiological genomics, . https://doi.org/10.1152/physiolgenomics.00119.2021
Gonzalez-Fernandez, Ezekiel, et al. "The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases." Physiological genomics vol. (2021). doi: https://doi.org/10.1152/physiolgenomics.00119.2021
Gonzalez-Fernandez E, Fan L, Wang S, Liu Y, Gao W, Thomas KN, Fan F, Roman RJ. The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases. Physiol Genomics. 2021 Dec 03; doi: 10.1152/physiolgenomics.00119.2021. Epub 2021 Dec 03. PMID: 34859687.
Copy Download .nbib Format: NLM
Showing 85 to 88 of 88 entries